Effects of heating coagulation of middle meningeal artery on plasma CGRP level and c-fos expression in migraine rat triggered by nitroglycerin

Neurological Sciences

Volumn 32, Issue 4, 2011, Pages 589-594

  Zhu, Xiaofeng ^a   Han, Yuechen ^a   Xiong, Wenping ^a   Liu, Wenwen ^b   Lu, Sumei ^b   Li, Jianfeng ^b   Wang, Haibo ^a,b   Fan, Zhaomin ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b Shandong Clinic Research Institute   (China)

Author keywords

C fos; Calcitonin gene related peptide; Middle meningeal artery; Migraine; Trigeminal nucleus caudalis

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; GLYCERYL TRINITRATE; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE ACTIVITY; GENE EXPRESSION; HEAT COAGULATION; HEAT TREATMENT; MENINGEAL ARTERY; MIGRAINE; NEUTRON ACTIVATION ANALYSIS; NONHUMAN; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; THERAPY EFFECT; TRIGEMINAL NUCLEUS; VASODILATATION;

ACTINS; ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; CALCITONIN GENE-RELATED PEPTIDE; DNA PRIMERS; FEMALE; HOT TEMPERATURE; MENINGEAL ARTERIES; MIGRAINE DISORDERS; NERVE TISSUE PROTEINS; NITROGLYCERIN; PROTO-ONCOGENE PROTEINS C-FOS; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEREOTAXIC TECHNIQUES; VASODILATOR AGENTS;

EID: 80053987035     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-011-0486-7     Document Type: Article

References (23)

1. Mehrotra S, Gupta S, Chan KY, Villalón CM, Centurión D, Saxena PR, MaassenVanDenBrink A (2008) Current and prospective pharmacological targets in relation to antimigraine action. Naunyn Schmiedebergs Arch Pharmaco 1378:371-394
2. Greco R, Tassorelli C, Cappelletti D, Sandrini G, Nappi G (2005) Activation of the transcription factor NF-kappaB in the nucleus trigeminalis caudalis in an animal model of migraine. Neurotoxicology 26:795-800 (Pubitemid 41427519)
3. Gallai V, Sarchielli P, Floridi A, Franceschini M, Codini M, Glioti G, Trequattrini A, Palumbo R (1995) Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia 15: 384-390
4. Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U, Pollentier S, Lesko LM (2004) Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 350:1104-1110 (Pubitemid 38298990)
5. Ho TW, Mannix LK, Fan X, Assaid C, Furtek C, Jones CJ, Lines CR, Rapoport AM (2008) Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology 70:1304-1312 (Pubitemid 351550355)
6. Ho TW, Ferrari MD, Dodick DW, Galet V, Kost J, Fan X, Leibensperger H, Froman S, Assaid C, Lines C, Koppen H, Winner PK (2008) Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene- related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebocontrolled, parallel-treatment trial. Lancet 372:2115-2125
7. Lassen L, Haderslev P, Jacobsen V, Iversen H, Sperling B, Olesen J (2002) CGRP may play a causative role in migraine. Cephalalgia 22:54-61 (Pubitemid 34626025)
8. Bergerot A, Holland PR, Akerman S, Bartsch T, Ahn AH, MaassenVanDenBrink A, Reuter U, Tassorelli C, Schoenen J, Mitsikostas DD, van den Maagdenberg AM, Goadsby PJ (2006) Animal models of migraine: looking at the component parts of a complex disorder. Eur J Neurosci 24:1517-1534 (Pubitemid 44429881)
9. Ter Horst GJ, Meijler WJ, Korf J, Kemper RH (2001) Trigeminal nociception-induced cerebral Fos expression in the conscious rat. Cephalalgia 21:963-975 (Pubitemid 34626033)
10. Juhasz G, Zsombok T, Modos EA, Olajos S, Jakab B, Nemeth J, Szolcsanyi J, Vitrai J, Bagdy G (2003) NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain 106:461-470 (Pubitemid 37505895)
11. Stepien A, Jagustyn P, Trafny EA, Widerkiewicz K (2003) Suppressing effect of the serotonin 5HT1B/D receptor agonist rizatriptan on calcitonin gene-related peptide (CGRP) concentration in migraine attacks. Neurol Neurochir Pol 37:1013-1023
12. Tassorelli C, Joseph SA (1995) Systemic nitroglycerin induces Fos immunoreactivity in brainstem and forebrain structures of the rat. Brain Res 682:167-181
13. Tassorelli C, Greco R, Morazzoni P, Riva A, Sandrini G, Nappi G (2005) Parthenolide is the component of tanacetum parthenium that inhibits nitroglycerin-induced Fos activation: studies in an animal model of migraine. Cephalalgia 25:612-621 (Pubitemid 41026027)
14. Offenhauser N, Zinck T, Hoffmann J, Schiemann K, Schuh-Hofer S, Rohde W, Arnold G, Dirnagl U, Jansen-Olesen I, Reuter U (2005) CGRP release and c-fos expression within trigeminal nucleus caudalis of the rat following glyceryltrinitrate infusion. Cephalalgia 25:225-336
15. Fan Z, Fan Z, Wang H (2006) New surgical approach for migraine. Otol Neurotol 27:713-715 (Pubitemid 44180486)
16. Tassorelli C, Greco R, Morocutti A, Costa A, Nappi G (2001) Nitric oxide-induced neuronal activation in the central nervous system as an animal model of migraine: mechanisms and mediators. Funct Neurol 16:69-76 (Pubitemid 34295896)
17. Ploug KB, Boni LJ, Baun M, Hay-Schmidt A, Olesen J, Jansen- Olesen I (2008) K (ATP) channel expression and pharmacological in vivo and in vitro studies of the K(ATP) channel blocker PNU- 37883A in rat middle meningeal arteries. Br J Pharmacol 154:72-81 (Pubitemid 351620410)
18. Strecker T, Dux M, Messlinger K (2002) Nitric oxide releases calcitonin-gene-related peptide from rat dura mater encephali promoting increases in meningeal blood flow. J Vasc Res 39:489-496 (Pubitemid 36091839)
19. Knyihar-Csillik E, Toldi J, Mihaly A, Krisztin-Péva B, Chadaide Z, Németh H, Fenyo R, Vécsei L (2007) Kynurenine in combination with probenecid mitigates the stimulation-induced increase of c-fos immunoreactivity of the rat caudal trigeminal nucleus in an experimental migraine model. J Neural Transm 114:417-421 (Pubitemid 46474855)
20. Knyihar-Csillik E, Mihaly A, Krisztin-Peva B, Robotka H, Szatmari I, Fulop F, Toldi J, Csillik B, Vecsei L (2008) The kynurenate analog SZR-72 prevents the nitroglycerol-induced increase of c-fos immunoreactivity in the rat caudal trigeminal nucleus: comparative studies of the effects of SZR-72 and kynurenic acid. Neurosci Res 61:429-432
21. Martin RS, Martin GR (2001) Investigation intomigraine pathogenesis: time course for effects of m.CPP, BW723C86 or glyceryltrinitrate on appearance of Fos-like immunoreactivity in rat trigeminal nucleuscaudalis (TNC). Cephalalgia 21:46-52 (Pubitemid 32304300)
22. Pardutz A, Krizbai I, Multon S, Vecsei L, Schoenen J (2000) Systemic nitroglycerin increases nNOS levels in rat trigeminal nucleus caudalis. Neuroreport 11:3071-3075
23. Lambert GA, Donaldson C, Boers PM, Zagami AS (2000) Activation of trigeminovascular neurons by glyceryl trinitrate. Brain Res 887:203-210 (Pubitemid 32008041)